Inc.'s stock has tumbled to a 52-week low, touching down at $2.6, a dramatic fall from its 52-week high of $74.5. According to InvestingPro analysis, the company's market capitalization has shrunk to ...

Annovis Bio Inc. (ANVS) stock has tumbled to a 52-week low, reaching a price level of just $2.59. With a market capitalization of $49.7 million, InvestingPro analysis indicates the stock is currently ...

S&P 500 Shake-Up: New Entrants Driving Market Momentum The S&P 500 is a widely recognized benchmark for the US stock market, and it has undergone reshuffling due to the quarterly rebalancing process.

Choreo LLC increased its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.3% in the fourth quarter, Holdings Channel reports. The firm owned 4,812 shares of the biotechnology company’s stock ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

Mustang Bio (MBIO) announced the pricing of a public offering of an aggregate of 2,657,807 shares of its common stock, Series C-1 warrants to ...

Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...